Sep 11, 2019 Through its fully owned subsidiary CanChew Biotechnologies, AXIM is the CanChew CBD Gum is a patented, all-natural CBD based gum Mar 13, 2019 AXIM Biotechnologies, a US-based company specialist in CBD research cannabinoids into its patented chewing gum delivery mechanism. Apr 30, 2019 Axim Biotechnologies Inc (OTCMKTS: AXIM) is trading close to a firm to commence clinical studies on Dronabinol and CBD chewing gums as Our flagship products include CanChew+®, a CBD-based controlled release chewing gum, CanChew+ 50®, containing 50 mg of CBD undergoing clinical trials
May 8, 2017 Preliminary tests for their gum products have been promising for AXIM: One recent study it conducted using its 50mg CBD gum product showed
Mar 22, 2019 “We are carrying hemp-derived CBD products in select states to help Axim's topical cream and a growing portfolio related to chewing gum. Sep 11, 2019 Through its fully owned subsidiary CanChew Biotechnologies, AXIM is the CanChew CBD Gum is a patented, all-natural CBD based gum Mar 13, 2019 AXIM Biotechnologies, a US-based company specialist in CBD research cannabinoids into its patented chewing gum delivery mechanism.
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing
Medical Marijuana, Inc. has announced that their Kannaway® has placed a substantial purchase order from AXIM Biotechnologies for its CBD nutraceutical chewing gum. Axim to build Dutch facility for cannabinoid-based chewing gum Axim Biotechnologies already uses cannabinoids in its nutraceutical chewing gum CanChew and is now looking to use similar ingredients and technology to bring the first “medical marijuana” product delivered by gum to market. CanChew CBD Gum | BuyHempCBDOil.com Product Description. CanChew CBD Gum is a patented, all-natural CBD based gum product.The ingredients in CanChew are of the highest purity and are steam-distilled — a meticulous process that preserves the integrity of the gum’s ingredients better than typical extraction methods. Under Development: CBD Pharmaceutical Chewing Gum - Drug About AXIM® AXIM® Biotechnologies, Inc. focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The company’s flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with
Oct 30, 2018 MedChew Rx, a type of gum produced by AXIM looks very promising. It contains 5 milligrams of CBD – a non-psychoactive component of
AXIM Biotech to Study CBD Gum For Drug-Induced Psychosis (Image Credit - Amy Elyse via Flickr) . AXIM Biotechnologies Inc. (OTC:AXIM) just announced that the company has entered into a clinical study agreement with the University of British Columbia to begin a clinical trial to study the effects of its cannabidiol (CBD) chewing gum on drug-induced psychosis in adult patients. AXIM Biotechnologies (AXIM) Advancing Multi-faceted Medical CBD 20.03.2018 · AXIM Biotechnologies is actively engaged in conducting research in order to develop oral, trans-mucosal, controlled-release delivery systems (primarily CBD-infused chewing gum treatments) for a AXIM Biotechnologies receives purchase order on its CBD gum, 13.02.2019 · AXIM Biotechnologies Inc (OTCQB: AXIM) CEO John Huemoeller tells Proactive Investors yesterday, the cannabinoid research and development has received an initial purchase order of 7,500 boxes from